trending Market Intelligence /marketintelligence/en/news-insights/trending/SdV9_4kVstZBuqJHMuVgCg2 content esgSubNav
In This List

ProQR Therapeutics appoints chief development strategy officer

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


ProQR Therapeutics appoints chief development strategy officer

ProQR Therapeutics NV appointed David Rodman as chief development strategy officer.

Rodman has served as a chief medical officer at miRagen Therapeutics Inc. and Nivalis Therapeutics Inc.